Anzeige
Mehr »
Freitag, 03.10.2025 - Börsentäglich über 12.000 News
Golden Cross macht sich bereit: 1.350 Goldabbaustellen, 55 Ladder-Ziele und ein historischer Volltreffer
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40C6G | ISIN: CA09076J2074 | Ticker-Symbol: 8MV0
München
03.10.25 | 08:00
7,900 Euro
-1,86 % -0,150
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOHARVEST SCIENCES INC Chart 1 Jahr
5-Tage-Chart
BIOHARVEST SCIENCES INC 5-Tage-Chart
RealtimeGeldBriefZeit
7,5007,70023:00

Aktuelle News zur BIOHARVEST SCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
BIOHARVEST SCIENCES Aktie jetzt für 0€ handeln
22.09.BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer-
22.09.BioHarvest sichert sich 10,9 Mio. US-Dollar und stärkt Bilanz durch Schuldenabbau1
22.09.BioHarvest raises $10.9 million through warrant exercises and debt conversions1
22.09.BioHarvest Sciences Inc.: BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction222Rehovot, Israel--(Newsfile Corp. - September 22, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis...
► Artikel lesen
10.09.BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer2
10.09.BioHarvest produces plant-based exosomes in bioreactors2
10.09.BioHarvest Sciences Inc.: BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale207Rehovot, Israel--(Newsfile Corp. - September 10, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology...
► Artikel lesen
08.09.Bioharvest Sciences Inc (2): Bioharvest files registration statement on Form F-31
02.09.BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer2
02.09.BioHarvest Sciences Inc.: BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET269Rehovot, Israel--(Newsfile Corp. - September 2, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology...
► Artikel lesen
14.08.Bioharvest Sciences Inc (2): Bioharvest extends insider trading window2
13.08.BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer1
11.08.BioHarvest Clears Breakeven on Q2 Numbers1
11.08.BioHarvest Sciences Inc.: BioHarvest Sciences Reports Second Quarter 2025 Financial Results392Rehovot, Israel--(Newsfile Corp. - August 11, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology...
► Artikel lesen
11.08.BioHarvest Sciences GAAP EPS of -$0.24 misses by $0.13, revenue of $8.5M misses by $0.03M3
05.08.BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer6
04.08.BioHarvest Sciences Inc.: BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time371Rehovot, Israel--(Newsfile Corp. - August 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology...
► Artikel lesen
23.07.BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer1
23.07.BIOHARVEST SCIENCES INC. - S-8, Securities to be offered to employees in employee benefit plans2
23.07.BioHarvest Sciences Inc.: BioHarvest Sciences to Present at Canaccord Genuity 45th Annual Growth Conference on August 12-14, 2025289Rehovot, Israel--(Newsfile Corp. - July 23, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology...
► Artikel lesen
Weiter >>
58 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1